tiprankstipranks
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market
42C
iX Biopharma Ltd.
RESEARCH TOOLSreports
Want to see SG:42C full AI Analyst Report?

iX Biopharma Ltd. (42C) Financial Statements

21 Followers

iX Biopharma Ltd. Financial Overview

iX Biopharma Ltd.'s market cap is currently S$519.32M. The company's EPS TTM is S$-0.0944; its P/E ratio is -70.90; iX Biopharma Ltd. is scheduled to report earnings on August 21, 2026, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total RevenueS$ 6.85MS$ 7.77MS$ 5.96MS$ 5.91MS$ 14.39M
Gross ProfitS$ 2.43MS$ 2.04MS$ 1.05MS$ 2.32MS$ 12.29M
Operating IncomeS$ -9.56MS$ -6.29MS$ -7.39MS$ -8.41MS$ 1.24M
EBITDAS$ -8.83MS$ -8.96MS$ -8.68MS$ -8.51MS$ -2.84M
Net IncomeS$ -7.99MS$ -10.14MS$ -10.79MS$ -9.62MS$ -4.60M
Balance Sheet
Cash & Short-Term InvestmentsS$ 14.73MS$ 866.00KS$ 1.77MS$ 6.52MS$ 13.49M
Total AssetsS$ 25.88MS$ 11.28MS$ 14.62MS$ 24.93MS$ 28.52M
Total DebtS$ 5.80MS$ 5.90MS$ 5.20MS$ 4.34MS$ 4.41M
Net DebtS$ -8.93MS$ 5.04MS$ 3.43MS$ -2.18MS$ -9.09M
Total LiabilitiesS$ 10.48MS$ 10.92MS$ 10.28MS$ 9.08MS$ 8.77M
Stockholders' EquityS$ 15.40MS$ 365.00KS$ 4.34MS$ 15.85MS$ 19.74M
Cash Flow
Free Cash FlowS$ -8.07MS$ -3.96MS$ -6.84MS$ -8.36MS$ 2.92M
Operating Cash FlowS$ -7.96MS$ -3.76MS$ -6.55MS$ -7.66MS$ 3.12M
Investing Cash FlowS$ -117.00KS$ -201.00KS$ 1.06MS$ -695.00KS$ -5.62M
Financing Cash FlowS$ 21.93MS$ 3.12MS$ 724.00KS$ 1.42MS$ 9.79M
Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History

Income Statement >

iX Biopharma Ltd. Debt to Assets

Balance Sheet >

iX Biopharma Ltd. Cash Flow

Cash Flow >

iX Biopharma Ltd. Forecast EPS vs Actual EPS

Earnings >